abstract |
The compound of formula (I) or a pharmaceutically acceptable salt thereof exhibits a 5-HT 1A receptor activating action in addition to the inhibition of noradrenaline reuptake, and optionally also a 5-HT reuptake inhibitor Useful for the treatment of obesity. |